基质金属蛋白酶及其抑制剂与喉癌的浸润和转移
被引量：1
摘要
喉癌是头颈部常见的恶性肿瘤，喉癌的浸润与转移是影响治疗效果和预后的主要因素。基质金属蛋白酶及基质金属蛋白酶抑制剂是调节许多生理和病理过程中细胞外基质及基底膜有序降解和重塑的重要分子。细胞外基质和基底膜的降解在喉癌和其他肿瘤的浸润转移过程中起重要作用，基质金属蛋白酶及其抑制剂在细胞外基质和基底膜的代谢平衡中起关键作用，因而与喉癌的浸润转移密切相关。本文对基质金属蛋白酶及其抑制剂在喉癌中的表达与喉癌浸润转移及预后的相关性作一综述，并对指导喉癌治疗进行了展望。
出处
《国际耳鼻咽喉头颈外科杂志》
2007年第3期174-177,共4页
International Journal of Otolaryngology-Head and Neck Surgery
参考文献19
-
1Kanayama HO, Yokota K, Kurokaw a Y, et al. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer, 1998, 82 (7) : 1359-1366.
-
2Itoh Y, Nagase H. Matrix metalloproteinases in cancer. Essays Biochem, 2002, 38 (1) : 21-36.
-
3Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J, 1991, 5 (8) 2145-2154.
-
4Visse R, Hideaki N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry. Cire Res, 2003, 92 (8):827-893.
-
5Seo Dw, Li H, Guedez L, et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell, 2003, 114 (2) : 171-180.
-
6Magary SP, Ryan MW, Tarnuzzer RW, et al. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in laryngeal and pharyngeal squamous cell carcinoma. A quantitative analysis. Otolaryngol Head Neck Surg, 2000, 122 (5) : 712-716.
-
7Krecicki T, Fraczek M, Jelen M, et al. Expression of collagenase-1 (MMP-1) , collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngealsquamous cell carcinomas. Eur Arch Otorhinolaryngol, 2003, 260 (9):494-497.
-
8Cazorla M, Hemandez L, Nadal A, et al. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol, 1998, 186 (5) : 144-150.
-
9Bogusiewicz M, Stryjecka-Zimmer M, Szymanski M, et al. Activity of matrix metalloproteinases-2 and-9 in advanced laryngeal cancer. Otolaryngol Head Neck Surg, 2003, 128 (1) : 132-136.
-
10Tokumaru Y, Fujii M, Otani Y, et al. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett, 2000, 150 (1) : 15-21.
二级参考文献4
-
1刘业海,唐平章,刘芝华,徐震纲,祁永发,李爱东,丁芳,张立勇,骆爱萍.基质金属蛋白酶14基因在人喉鳞状细胞癌中表达差异的分析[J].中华耳鼻咽喉科杂志,2004,39(8):501-506. 被引量：7
-
2Ya-nanSun YuanLi.EXPRESSION OF mRNA FOR MEMBRANE-TYPE 1, 2, AND 3 MATRIX METALLOPROTEINASES IN HUMAN LARYNGEAL CANCER[J].Chinese Medical Sciences Journal,2004,19(3):170-173. 被引量：5
-
3杨翠红,刘芝华,王群,骆爱萍,王秀琴,孙耘田,张洵,周传农,吴旻.基质金属蛋白酶基因MMP20在人食管癌发生发展中的表达差异分析[J].科学通报,2001,46(5):405-407. 被引量：3
-
4刘业海,唐平章,祁永发,徐震纲.气管造口复发癌的处理[J].中华耳鼻咽喉科杂志,2002,37(5):380-383. 被引量：13
同被引文献11
-
1李为,刘卫卫,白文忠,施惠晶.MMP-7和TIMP-1在喉癌中的表达[J].中国耳鼻咽喉头颈外科,2007,14(7):406-406. 被引量：1
-
2Galardy RE. Galardin[J], Drugs Future,1993, 18 ( 12):1109-1111.
-
3Grobelny D,Poncz L,Galardy RE. Inhibition of humanskin fibroblast collagenase,thermolysin, and Pseudo-monas aeruginosa elastase by peptide hydroxamic acids[J]. Biochemistry, 1992,31 (20) :7152-7154.
-
4Bode W,Fernandez-Catalan C,Tschesche,et al. Structuralproperties of matrix metalloproteinases [J]. Cell MollifeSci,1999,55(4):639-652.
-
5Suarez-Cuetwo C,Merrell MA, Watson I,et al. Breastcancer cells with inhibition of p38alpha have decreasedMMP-9 activity and exhibit decreased bone metastasis inmice[J]. Clin Exp Metastasis,2004,21(6) : 525-533.
-
6Xu D, McKee CM, Cao Y, et al. Matrix metalloproteinase-9regulates tumor cell invasion through cleavage of proteasenexin-l[J]. Cancer research,2010,70(17) :6988-6998.
-
7Sun Y,Liu M, Yang B,et al. Inhibition of laryngeal cancercell invasion and growth with lentiviral-vector deliveredshort hairpin RNA targeting human MMP-9 gene [ J].Cancer invest,2008,26(10) :984-989.
-
8Almholt K,Juncker-Jensen A,Lorum OD,et al. Metastasis is strongly reduced by the matrixmetalloproteinase inhibitor Galardin in the MMTV-PymTtransgenic breast cancer model[J], Molecular cancer ther-apeutics ,2008,7(9):2758-2767.
-
9Hao JL, Nagano T,Nakamura M, et al. Galardin inhibitscollagen degradation by rabbit keratocytes by inhibitingthe activation of pro-matrix metalloproteinases [ J]. ExpEye Res,1999,68(5) :565-572.
-
10黄万钟,姚月华,钟瑜,鲍洁,潘达超.长春瑞滨联合卡培他滨治疗难治性鼻咽癌的临床观察[J].中国实用医药,2009,4(34):30-31. 被引量：1
-
1郝青,郭颖,张林西.基质金属蛋白酶及其抑制剂在消化系统肿瘤中作用的研究进展[J].河北北方学院学报（自然科学版）,2012,28(6):102-105. 被引量：1
-
2孙丽丽,郑颖,高虹,王宏,汪晓春,王宏东,白兰,金惠.多西紫杉醇对人喉癌细胞Hep-2增殖的抑制作用[J].中国生物制品学杂志,2010,23(7):748-750.
-
3卢大用,曹静懿,黄延平,龚镥,陈雪良,陈恩鸿,胥彬.Comparison of some antineoplastic drugs on inhibiting thrombin catalizing fibrinogen clotting in vitro[J].Chinese Medical Journal,1999(11):93-94. 被引量：1
-
4钟伟,张剑.内皮素及其受体的研究进展[J].中国眼耳鼻喉科杂志,2006,6(2):128-130.
-
5邢文缘,肖占荣,董少辉.近十年住院喉癌病例动态分析[J].黑龙江医药,1992(4):7-8.
-
6侯艳鹏,王铁.RhoB—mRNA在喉癌中的表达及其临床意义[J].肿瘤研究与临床,2009,21(9):614-615.
-
7叶京英,李晓丹,王久莉,史历,吕明刚.平阳霉素治疗人喉鳞状细胞癌的实验研究[J].哈尔滨医科大学学报,1995,29(2):141-141. 被引量：1
-
8杨菊红,王栋,王新允.基质金属蛋白酶及其抑制剂与肺癌[J].中国肺癌杂志,2002,5(1):76-78. 被引量：1
-
9邵惠姣,方荣凤.利多卡因用于喉肿瘤术后吸引的观察[J].浙江实用医学,2001,6(2):53-53.
-
10高立生,徐勤,刘吉娜,刘晓东,高珊.喉鳞癌组织中VEGF-C和VEGFR-3的表达及临床意义[J].临床和实验医学杂志,2014,13(20):1688-1690.
